 |
Bluebird Bio
Last updated: July 30, 2024
Nick Leschly, CEO
USA | Funding: $3.4B (+)
Website: https://www.bluebirdbio.com/
Bluebird Bio offers products based on the transformative potential of gene therapy for patients with genetic and orphan diseases.
Website: https://www.bluebirdbio.com/
Bluebird Bio offers products based on the transformative potential of gene therapy for patients with genetic and orphan diseases.
